Controlled Pilot Trial of Monthly Intravenous Cyclophosphamide in Multiple Sclerosis

Archives of Neurology

Volumn 45, Issue 1, 1988, Pages 27-30

  Killian, James M ^a   Bressler, Robert B ^a   Armstrong, Richard M ^a   Huston, David P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

CLINICAL ARTICLE; CONTROLLED STUDY; HAIR LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; NAUSEA; PRIORITY JOURNAL; VOMITING;

ADULT; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PILOT PROJECTS; RANDOM ALLOCATION; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0023836524     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1988.00520250033014     Document Type: Article

References (24)

1. 1. Ellison GW, Myers LW: A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis. Neurology 1978;28:132-139.
2. 2. Lhermitte F, Marteau R, Roullete E, et al: Prolonged treatment of multiple sclerosis with average doses of azathioprine: Long-term immunosuppression in multiple sclerosis: An evaluation of 15 years‧ experience. Rev Neurol 1984;140:553-558.
3. 3. Lance EM, Kremer M, Abbosh J, et al: Intensive immunosuppression in patients with disseminated sclerosis. Clin Exp Immunol 1975;21:1-12.
4. 4. Mertin J, Kremer M, Knight SC, et al: Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: Final report. Lancet 1982;2:351-353.
5. 5. Ferguson TB, Clifford DB, Montgomery EB, et al: Thymectomy in multiple sclerosis. J Thorac Cardiovasc Surg 1983;85:88-93.
6. 6. Dau PC, Petajan JH, Johnson KP, et al: Plasmapheresis in multiple sclerosis: Preliminary findings. Neurology 1980;30:1023-1028.
7. 7. Tindall RS, Walker JI, Ehle AL, et al: Plasmapheresis in multiple sclerosis, prospective trial of pheresis and immunosuppression versus immunosuppression alone. Neurology 1982;32:739-743.
8. 8. Millac P, Miller H: Cyclophosphamide in multiple sclerosis. Lancet 1969;1:783.
9. 9. Hommes OR, Lamers KJB, Reekers P: Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis. J Neurol 1980;223:177-190.
10. 10. Theys P, Gosseye-Lissoir F, Ketelaer P, et al: Short-term intensive cyclophosphamide treatment in multiple sclerosis. J Neurol 1981;225:119-134.
11. 11. Khatri BO, McQuillen MD, Harrington GJ, et al: Chronic progressive multiple sclerosis: Double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 1985;35:312-319.
12. 12. Gonsette RE, Demonty L, Delmotte P: Intensive immunosuppression with cyclophosphamide in multiple sclerosis: A follow-up of 110 patients for two to six years. J Neurol 1977;214:173-181.
13. 13. Hauser S, Dawson D, Weiner HL, et al: Intensive immunosuppression in progressive multiple sclerosis: A randomized three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-180.
14. 14. Huston DB, White MJ, Bressler RB, et al: Immune suppression for multiple sclerosis. N Engl J Med 1983;309:240-241.
15. 15. Kurtzke JF: Further notes on disability evaluation in multiple sclerosis. Neurology 1965;15:654-661.
16. 16. Cassileth PA, Lusk EJ, Tori S, et al: Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 1983;143:1347-1349.
17. 17. Goodman S, Isacson R, Gerra C, et al: High-dose metoclopramide and dexamethasone as an antiemetic in chemotherapy of breast cancer. Oncology 1986;43:173-175.
18. 18. Austin HA, Klippel JH, Balow JE, et al: Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-619.
19. 19. Morimoto C, Hafler DA, Weiner HL, et al: Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis: Analysis with anti-2H4 monoclonal antibody. N Engl J Med 1987;316:67-78.
20. 20. Schilsky RI, Lewis BJ, Sherius RJ, et al: Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med 1980;93:109-114.
21. 21. Weiss RB, Salvador B: Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 1981;94:66-72.
22. 22. Kim HC, Kesarwala HH, Colvin M, et al: Hypersensitivity reaction to a metabolite of cyclophosphamide. J Allergy Clin Immunol 1985;76:591-594.
23. 23. Millar JH, Vas CJ, Noronha MJ, et al: Long-term treatment of multiple sclerosis with corticotrophin. Lancet 1967;2:429-431.
24. 24. Fog T: The long-term treatment of multiple sclerosis with corticoids. Acta Neurol Scand 1965;13(suppl):473-484.